ARMISTICE CAPITAL, LLC
SEC CIK 1601086 · EDGAR
BoughtSold
Most active insiders at AVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sullivan Christopher Ryan | CFO | — | $3.72M |
| 2 | Doyle Mittie | Chief Medical Off | — | $2.98M |
| 3 | VARKI PAUL | CLO | — | $1.51M |
| 4 | Goldman Jonathan | Dir | — | $163.0K |
| 5 | Chan Mitchell | Dir | — | $72.5K |
| 6 | Riley Jennifer | Chief Strategy Off | — | $52.0K |
| 7 | Truex Samantha | Dir | — | — |
| 8 | KANTOFF AARON | Dir | — | — |
| 9 | NEIL GARRY ARTHUR | CEO, Dir | — | — |
| 10 | KAPLAN GILLA | Dir | — | — |
ARMISTICE CAPITAL, LLC made no open-market trades at AVTX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-02-09 | 2023-02-03 | AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | 10% | L - Small Acq | $3.95 | +334 | 3.96M | +0.0% | +$1,319 |
| DI | 2023-02-09 | 2023-02-07 | AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | 10% | P - Purchase | — | +450.0K | 4.42M | +11% | — |
| MI | 2022-03-14 | 2022-03-10+ | AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | Dir, 10% | P - Purchase | $0.6735 | +226.0K | 47.58M | +0.5% | +$152.2K |
| MI | 2022-01-20 | 2022-01-18+ | AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | Dir, 10% | P - Purchase | $0.8788 | +312.0K | 46.40M | +0.7% | +$274.2K |
| MI | 2021-09-17 | 2021-09-15+ | AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | Dir, 10% | P - Purchase | $2.20 | +5.70M | 45.00M | +15% | +$12.56M |
| MI | 2021-08-06 | 2021-08-04+ | AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | Dir, 10% | P - Purchase | $2.73 | +150.0K | 39.20M | +0.4% | +$409.0K |
| MI | 2021-08-03 | 2021-07-30+ | KPRX | KIORA PHARMACEUTICALS INC | ARMISTICE CAPITAL, LLC | 10% | S - Sale | $2.48 | -261.0K | 977.8K | -21% | -$646.1K |
Purchase Sale Sale after option exercise All abbreviations